These shares are ending the week positively. But why? The post Why Bowen Coal, Droneshield, Mesoblast, and St Barbara shares ...

Mesoblast Limited (AU:MSB) has released an update.Don't Miss Our Christmas Offers:Discover the latest stocks recommended by top Wall Street ...

WuXi Apptec will sell its Advanced Technologies unit to the US private equity firm Altaris for an undisclosed amount, a ...

Email Alerts for: Current price: $2.63 Market cap: $3.93bn Current price: $3.01 Current price: $2.31 Current price: $3.69 ...

If you thought crypto investors need to have strong stomachs, spare a thought for the investors who try their luck in the ...

Mesoblast (NASDAQ:MESO – Get Free Report) was downgraded by investment analysts at Jefferies Financial Group from a “buy” rating to a “hold” rating in a research report issued on Monday, MarketBeat ...

Regenerative medicine company Mesoblast Ltd. received an early Christmas present from the FDA for approval of its allogeneic bone marrow-derived mesenchymal stromal cell (MSC) therapy, Ryoncil ...

Fintel reports that on December 23, 2024, Jefferies downgraded their outlook for Mesoblast Limited - Depositary Receipt () ...

Mesoblast Limited, global leader in allogeneic cellular medicines for inflammatory diseases, announced the Food and Drug Administration (FDA) approved Ryoncil (remestemcel-L) as the first mesenchymal ...

Jefferies downgraded Mesoblast (MESO) to Hold from Buy with a price target of A$2.30, up from A$1.10. The firm updated the company’s for the ...

The ASX is set to rise as the NASDAQ edges closer to its record high, rebounding from last week’s sell-off as investors ...

GEN presents data compiled by Morningstar's Morningstar Direct asset management platform for StockWatch of the top five ...